Fore Capital’s Amgen AMGN Stock Holding History

Fore Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,000	Closed	-$1.61M	–	66
2020 Q4	$1.61M	Buy	+7,000	New	+$1.61M	0.39%	34

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fore Capital's AMGN Position: Q1 2021 in Review

Fore Capital sold out of Amgen (AMGN) in Q1 2021, closing a stake of 7,000 shares — an estimated $1.61M sold.

Fore Capital first reported a position in AMGN in Q4 2020 and held it in 1 quarter. The position peaked at $1.61M in Q4 2020. 2,217 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

Fore Capital reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
Fore Capital sold 7,000 Amgen shares in Q1 2021, an estimated $1.61M.
Fore Capital first reported a position in Amgen in Q4 2020 and held it in 1 quarter.
Fore Capital's Amgen position peaked at $1.61M in Q4 2020.
2,217 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Fore Capital's 13F filing for Q1 2021, filed 17 May 2021.